GLP-1 Semaglutide 10 MG

$90.00

Revolutionize your metabolic and body composition research with GLP-1 Semaglutide (10 MG), the premier long-acting incretin agonist transforming the landscape of glycemic and nutritional science. Renowned for its exceptional ability to modulate appetite pathways, optimize metabolic efficiency, and support cardiometabolic health, this powerhouse peptide features an extended 7-day biological half-life for effortless, once-weekly experimental precision. Whether you are investigating innovative weight management models or pioneering breakthroughs in energy homeostasis, our ultra-pure, HPLC-verified Semaglutide delivers elite-tier consistency and unmatched reliability for your most ambitious laboratory achievements.

10 MG

Per vial

Lyophilized Powder

Form

99.1%

Purity

Property

Value

CAS #

910463-68-2

Molecular Formula

C₁₈₇H₂₉₁N₄₅O₅₉

Molecular Weight

~4113.58 g/mol

Half-life

Approximately 7 days (~165–168 hours)

Origin

Synthetic

Development Stage

DA-approved clinical therapeutic (for Type 2 Diabetes and Chronic Weight Management); ongoing clinical trial investigation for cardiovascular risk reduction, kidney disease, non-alcoholic steatohepatitis (MASH/NAFLD), and neuroprotection

Mechanism

Selective glucagon-like peptide-1 (GLP-1) receptor agonist sharing 94% structural homology with native GLP-1. It mimics endogenous incretin hormones by activating pancreatic β-cell receptors to enhance glucose-dependent insulin secretion and suppress glucagon release, while simultaneously delaying gastric emptying and engaging central nervous system satiety pathways to reduce appetite and caloric intake.
Research References
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The Pinnacle of Metabolic Research & Incretin Axis Optimization

Investigate the forefront of metabolic science and endocrinology with GLP-1 Semaglutide (10 MG), a highly potent, long-acting glucagon-like peptide-1 receptor agonist engineered for advanced laboratory research. Sharing a striking 94% structural homology with native human GLP-1, Semaglutide is meticulously modified with a 2-aminoisobutyric acid (Aib) substitution at position 8 to prevent rapid metabolic inactivation by dipeptidyl peptidase-4 (DPP-4) enzymes. Furthermore, its structure features an elongated C-18 fatty diacid side chain at Lys²⁶ via a hydrophilic spacer, promoting highly reversible binding to serum albumin.

This brilliant molecular engineering shifts its biological half-life to an extended 7 days, providing researchers with a highly stable, predictable model to study sustained energy homeostasis, chronic glycemic regulation, and central satiety pathways without the volatility of short-lived native peptides.

Key Product Highlights

  • Extended Biological Persistence: Mechanistically optimized with an acylated fatty acid chain that drives high-affinity albumin binding, enabling a sustained 7-day pharmacokinetic profile perfect for investigating long-term, once-weekly experimental dosing models.

  • Enzymatic Degradation Immunity: Incorporates a strategic amino acid modification (Aib⁸) that acts as a structural shield, rendering the peptide highly resistant to DPP-4 cleavage and ensuring maximum bioavailability within cell and tissue cultures.

  • Dual Pancreatic Pathway Modulation: Selectively binds to and activates pancreatic $\beta$-cell GLP-1 receptors to stimulate glucose-dependent insulin secretion, while simultaneously interacting with $\alpha$-cells to suppress postprandial glucagon release.

  • Central Appetite & Gastric Kinetics Regulation: Serves as a primary tool for mapping central nervous system satiety pathways, exploring delayed gastric emptying rates, and evaluating down-regulated caloric intake and energy expenditure mechanisms.

  • Systemic Pleiotropic Protection: Ideal for evaluating multi-organ tissue protection, including the down-regulation of vascular endothelial inflammation, renal function preservation, and cardioprotective pathways in metabolic syndrome models.

  • Ultra-Pure Specification: Synthesized and lyophilized at an elite >99% purity level (HPLC and Mass Spectrometry verified) to guarantee flawless experimental reproducibility and uncompromised baseline metrics.

NOTE

This product is intended for laboratory research use only (RUO). Not for human or veterinary use.

DISCLAIMER

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Peak Vitality peptides have not been approved by Health Canada. Products by Peak Vitality have not been assessed for safety, efficacy and/or quality, may pose a range of serious health risks, and are intended for research purposes only. Products sold under Peak Vitality are not intended to treat, cure, or prevent diseases and/or conditions and may cause serious side effects.

You might also like

Tirzepatide 10 MG

$60.00

Tesamorelin (10 MG)

$125.00

Ipamorelin (5 MG)

$40.00

Retatrutide (10 MG)

$90.00

Elevate Your Performance

Pharmaceutical-grade peptides. Third-party verified. Backed by published research.

Product Categories